Antibacterial Activity of Alchornea cordifolia (Christmas bush) Leaves Extract on Carbapenem Resistant Enterobacteriaceae Causing Multi-drug Resistant Systemic Infections [PDF]
Carbapenems have been used for the treatment of systemic infections caused by Enterobacteriaceae. However, recent studies suggested that some Enterobacteriaceae are producing carbapenemases, which has limited the treatment options for carbapenem ...
Azumah, Bright Kojo +5 more
core +1 more source
BackgroundThe colonization of preterm neonates by multidrug-resistant Enterobacteriaceae, especially in neonatal intensive care units (NICUs), remains poorly understood despite its potential role in healthcare-associated transmission.
Eman Mohammed El-Shanqetti +4 more
doaj +1 more source
Background: The isolation of carbapenemase-producing Enterobacteriaceae (CPE) has become increasingly common. Continuous surveillance for these organisms is essential because their infections are closely related to outbreaks of illness and are ...
Bareum Gwon +6 more
doaj +1 more source
Clinical features and patient characteristics associated with carbapenem-resistant Enterobacteriaceae isolates producing NDM-1. [PDF]
Clinical features and patient characteristics associated with carbapenem-resistant Enterobacteriaceae isolates producing NDM-1.
Vincent O. Rotimi (761006) +2 more
core +1 more source
Susceptibility of Tigecycline against Carbapenem Resistant Enterobacteriaceae
Background: Enterobacteriaceae, a large family of Gram-negative bacteria, are one of the commonest etiological agents causing serious bacterial infections to humans. Carbapenems are the group of antibiotics with a broad spectrum of antimicrobial action.
Madeeha Fatima +2 more
doaj +1 more source
Aims: Carbapenems are usually the choice of antimicrobials in infections caused by Enterobacteriaceae bacteria-producing ESBL (extended spectrum β-lactamases) and Amp C.
Priya Datta +3 more
doaj +1 more source
Aims and Objectives: Carbapenemase production among clinical isolates of Enterobacteriaceae has been widely reported with prevalence rates ranging from between 2.8% and 53.6%. The aim of this study was to assess the prevalence of carbapenemase production
O O Oduyebo +3 more
doaj +1 more source
Weekly cases of selected notifiable diseases ( 65 1,000 cases reported during the preceding year), and selected low frequency diseases, United States and U.S. territories, week ending December 8, 2018 (WEEK 49). TABLE 2b, Carbapenemase-producing carbapenem-resistant Enterobacteriaceae [PDF]
2018-49-table2B-H.pdfCarbapenem-producing Carbapenem -resistant ...
core
AIM: We aimed to evaluate the effectiveness of a modified Carbapenem Inactivation Method (CIM) in detecting carbapenemase production among different clinical Enterobacteriaceae strains.
Asiye Karakullukçu, Gökhan Aygün
doaj +1 more source
Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections
Carbapenem-resistant Enterobacteriaceae (CRE) have become a public health threat worldwide. There are three major mechanisms by which Enterobacteriaceae become resistant to carbapenems: enzyme production, efflux pumps and porin mutations.
Beatriz Suay-García +1 more
doaj +1 more source

